T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cummins
CMI
$87.8B
| $565M | 0.05% |
2,517,053
-2,067,097
| -45% | -$484M |
|
327
GSK
GSK
$101B
| $565M | 0.05% |
11,822,494
+87,602
| +0.7% | +$4.4M |
|
328
FirstEnergy
FE
$27.2B
| $564M | 0.05% |
15,842,156
+492,184
| +3% | +$18.7M |
|
329
Devon Energy
DVN
$49.3B
| $562M | 0.05% |
15,833,026
-16,825,397
| -52% | -$477M |
|
330
Amgen
AMGN
$225B
| $557M | 0.05% |
2,621,390
-99,938
| -4% | -$23M |
|
331
PTC
PTC
$16.1B
| $549M | 0.05% |
4,583,570
+951,346
| +26% | +$127M |
|
332
Webster Financial
WBS
$12.8B
| $546M | 0.05% |
10,021,502
-393,107
| -4% | -$19.6M |
|
|
NVRO
333
DELISTED
NEVRO CORP.
NVRO
| $544M | 0.05% |
4,671,765
+226
| +0% | +$29.6K |
|
334
Crown Castle
CCI
$31.5B
| $540M | 0.05% |
3,113,535
-227,338
| -7% | -$43.9M |
|
|
VMEO
335
DELISTED
Vimeo
VMEO
| $538M | 0.05% |
18,323,791
-1,098,862
| -6% | -$43.3M |
|
336
Travelers Companies
TRV
$77.2B
| $535M | 0.05% |
3,518,365
+1,031,007
| +41% | +$160M |
|
337
Trade Desk
TTD
$6.34B
| $523M | 0.05% |
7,442,645
+6,379,951
| +600% | +$493M |
|
338
Endava
DAVA
$162M
| $522M | 0.05% |
3,845,249
+482,128
| +14% | +$62.2M |
|
339
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $513M | 0.05% |
5,454,761
-240,602
| -4% | -$22.1M |
|
340
Micron Technology
MU
$1.03T
| $511M | 0.05% |
7,194,876
+1,782,981
| +33% | +$134M |
|
341
Littelfuse
LFUS
$11.7B
| $507M | 0.05% |
1,855,941
+218,630
| +13% | +$58.3M |
|
342
EQT Corp
EQT
$33.8B
| $505M | 0.05% |
24,679,560
-3,983,390
| -14% | -$77.1M |
|
343
Biogen
BIIB
$30.9B
| $505M | 0.05% |
1,784,136
+171,573
| +11% | +$56.2M |
|
344
BWX Technologies
BWXT
$15.8B
| $503M | 0.05% |
9,346,644
-465,786
| -5% | -$26.2M |
|
345
Flowers Foods
FLO
$1.52B
| $500M | 0.05% |
21,143,953
+527,939
| +3% | +$12.5M |
|
346
Dollar Tree
DLTR
$24.7B
| $498M | 0.05% |
5,202,312
-4,305,297
| -45% | -$414M |
|
347
AXIS Capital
AXS
$7.26B
| $494M | 0.05% |
10,737,002
+127,443
| +1% | +$6.32M |
|
348
SBA Communications
SBAC
$19.4B
| $493M | 0.05% |
1,491,263
+89,978
| +6% | +$31.1M |
|
|
KL
349
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $492M | 0.05% |
11,822,897
+13,925
| +0.1% | +$566K |
|
350
Regeneron Pharmaceuticals
REGN
$82.2B
| $490M | 0.05% |
809,840
-15,004
| -2% | -$9.31M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.